NICE backs ‘revolutionary’ new drug for MS patients
A multiple sclerosis drug that need only be taken twice has been recommended for use in the NHS by the National Institute for Health and Care Excellence.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units